ESE Annual Review 2024
2024: A Landmark Year
2024 was a landmark year for the Society, with the launch of two new journals, several new partnerships which led to new initiatives including the first Joint Guideline with the Endocrine Society, the first Adrenal Patient Forum and the distribution of 246 grants for our robust programme of educational events.
The ESE team grew to 20 people, representing nine European countries plus Australia and New Zealand.
The Annual Review provides an account of activities and progress against the four pillars of ESE’s plan for the future:
- to unite and represent the European endocrine community
- to support our members
- to advance the science and clinical care of our discipline
- to be sustainable, trusted and valued.
You can read the review as a pdf or see a digital version, using the links below.